nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinchocaine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—COMT—conduct disorder	0.123	0.124	CbGpPWpGaD
Cinchocaine—BCHE—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—conduct disorder	0.122	0.123	CbGpPWpGaD
Cinchocaine—BCHE—Peptide hormone metabolism—CGA—conduct disorder	0.0412	0.0415	CbGpPWpGaD
Cinchocaine—CALM2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0272	0.0274	CbGpPWpGaD
Cinchocaine—CALM1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0272	0.0274	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0223	0.0225	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0195	0.0196	CbGpPWpGaD
Cinchocaine—CALM3—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.0177	0.0178	CbGpPWpGaD
Cinchocaine—CALM2—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.0171	0.0172	CbGpPWpGaD
Cinchocaine—CALM1—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.0171	0.0172	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.0168	0.0169	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by VEGF—WASF1—conduct disorder	0.0167	0.0168	CbGpPWpGaD
Cinchocaine—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0167	0.0168	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by VEGF—WASF1—conduct disorder	0.0161	0.0163	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by VEGF—WASF1—conduct disorder	0.0161	0.0163	CbGpPWpGaD
Cinchocaine—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0161	0.0163	CbGpPWpGaD
Cinchocaine—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0161	0.0163	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—GABRA2—conduct disorder	0.0149	0.015	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.0137	0.0138	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0125	0.0126	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0121	0.0122	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0121	0.0122	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—GABRA2—conduct disorder	0.00961	0.00968	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—COMT—conduct disorder	0.00938	0.00945	CbGpPWpGaD
Cinchocaine—BCHE—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00931	0.00938	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—GABRA2—conduct disorder	0.00929	0.00937	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—GABRA2—conduct disorder	0.00929	0.00937	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.009	0.00907	CbGpPWpGaD
Cinchocaine—CALM3—IFN-gamma pathway—EP300—conduct disorder	0.00885	0.00892	CbGpPWpGaD
Cinchocaine—CALM2—IFN-gamma pathway—EP300—conduct disorder	0.00856	0.00863	CbGpPWpGaD
Cinchocaine—CALM1—IFN-gamma pathway—EP300—conduct disorder	0.00856	0.00863	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of proteins—CGA—conduct disorder	0.00777	0.00784	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—MB21D1—conduct disorder	0.00743	0.00749	CbGpPWpGaD
Cinchocaine—CALM3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00738	0.00744	CbGpPWpGaD
Cinchocaine—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.00724	0.0073	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—MB21D1—conduct disorder	0.00719	0.00725	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—MB21D1—conduct disorder	0.00719	0.00725	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—COMT—conduct disorder	0.00718	0.00724	CbGpPWpGaD
Cinchocaine—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00714	0.00719	CbGpPWpGaD
Cinchocaine—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00714	0.00719	CbGpPWpGaD
Cinchocaine—BCHE—Neuronal System—MAOA—conduct disorder	0.00713	0.00719	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00604	0.00608	CbGpPWpGaD
Cinchocaine—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00599	0.00604	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00584	0.00589	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00584	0.00589	CbGpPWpGaD
Cinchocaine—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0058	0.00584	CbGpPWpGaD
Cinchocaine—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.0058	0.00584	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—POLR3A—conduct disorder	0.00545	0.0055	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—POLR3A—conduct disorder	0.00528	0.00532	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—POLR3A—conduct disorder	0.00528	0.00532	CbGpPWpGaD
Cinchocaine—CALM1—autonomic nervous system—conduct disorder	0.00464	0.588	CbGeAlD
Cinchocaine—CALM3—Neuronal System—COMT—conduct disorder	0.00462	0.00466	CbGpPWpGaD
Cinchocaine—CALM3—Neuronal System—MAOA—conduct disorder	0.00459	0.00463	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—WASF1—conduct disorder	0.00459	0.00463	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—COMT—conduct disorder	0.00447	0.00451	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—COMT—conduct disorder	0.00447	0.00451	CbGpPWpGaD
Cinchocaine—CALM2—Neuronal System—MAOA—conduct disorder	0.00444	0.00448	CbGpPWpGaD
Cinchocaine—CALM1—Neuronal System—MAOA—conduct disorder	0.00444	0.00448	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—WASF1—conduct disorder	0.00444	0.00448	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—WASF1—conduct disorder	0.00444	0.00448	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—MB21D1—conduct disorder	0.00433	0.00436	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—MB21D1—conduct disorder	0.00419	0.00422	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—MB21D1—conduct disorder	0.00419	0.00422	CbGpPWpGaD
Cinchocaine—SCN10A—Developmental Biology—EP300—conduct disorder	0.0041	0.00413	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—CGA—conduct disorder	0.00401	0.00404	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.00365	0.00368	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.00353	0.00356	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.00353	0.00356	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—POLR3A—conduct disorder	0.00318	0.0032	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—POLR3A—conduct disorder	0.00307	0.0031	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—POLR3A—conduct disorder	0.00307	0.0031	CbGpPWpGaD
Cinchocaine—SCN5A—Developmental Biology—EP300—conduct disorder	0.00288	0.0029	CbGpPWpGaD
Cinchocaine—CALM3—Immune System—WASF1—conduct disorder	0.00267	0.0027	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—WASF1—conduct disorder	0.00259	0.00261	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—WASF1—conduct disorder	0.00259	0.00261	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—CGA—conduct disorder	0.00258	0.0026	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—CGA—conduct disorder	0.0025	0.00252	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—CGA—conduct disorder	0.0025	0.00252	CbGpPWpGaD
Cinchocaine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.00234	0.00236	CbGpPWpGaD
Cinchocaine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.00226	0.00228	CbGpPWpGaD
Cinchocaine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.00226	0.00228	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	0.00217	0.00219	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—CGA—conduct disorder	0.00216	0.00217	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	0.0021	0.00212	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	0.0021	0.00212	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—CGA—conduct disorder	0.00209	0.0021	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—CGA—conduct disorder	0.00209	0.0021	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—DRD4—conduct disorder	0.00205	0.00206	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—DRD4—conduct disorder	0.00198	0.00199	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—DRD4—conduct disorder	0.00198	0.00199	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—COMT—conduct disorder	0.00181	0.00182	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—MAOA—conduct disorder	0.0018	0.00181	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by Wnt—EP300—conduct disorder	0.00179	0.0018	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00174	0.00176	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by Wnt—EP300—conduct disorder	0.00173	0.00175	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by Wnt—EP300—conduct disorder	0.00173	0.00175	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—WASF1—conduct disorder	0.00173	0.00174	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—WASF1—conduct disorder	0.00167	0.00169	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—WASF1—conduct disorder	0.00167	0.00169	CbGpPWpGaD
Cinchocaine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	0.00133	0.00134	CbGpPWpGaD
Cinchocaine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	0.00129	0.0013	CbGpPWpGaD
Cinchocaine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	0.00129	0.0013	CbGpPWpGaD
Cinchocaine—CALM3—Hemostasis—EP300—conduct disorder	0.00123	0.00124	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—DRD4—conduct disorder	0.00121	0.00122	CbGpPWpGaD
Cinchocaine—CALM1—Hemostasis—EP300—conduct disorder	0.00119	0.0012	CbGpPWpGaD
Cinchocaine—CALM2—Hemostasis—EP300—conduct disorder	0.00119	0.0012	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—DRD4—conduct disorder	0.00117	0.00118	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—DRD4—conduct disorder	0.00117	0.00118	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—COMT—conduct disorder	0.00116	0.00117	CbGpPWpGaD
Cinchocaine—CALM3—Metabolism—MAOA—conduct disorder	0.00116	0.00117	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—COMT—conduct disorder	0.00113	0.00114	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—COMT—conduct disorder	0.00113	0.00114	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—MAOA—conduct disorder	0.00112	0.00113	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—MAOA—conduct disorder	0.00112	0.00113	CbGpPWpGaD
Cinchocaine—CALM3—Innate Immune System—EP300—conduct disorder	0.00111	0.00112	CbGpPWpGaD
Cinchocaine—CALM2—Innate Immune System—EP300—conduct disorder	0.00107	0.00108	CbGpPWpGaD
Cinchocaine—CALM1—Innate Immune System—EP300—conduct disorder	0.00107	0.00108	CbGpPWpGaD
Cinchocaine—CALM3—Signaling Pathways—HTR2A—conduct disorder	0.000788	0.000794	CbGpPWpGaD
Cinchocaine—BCHE—Metabolism—EP300—conduct disorder	0.000776	0.000782	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—HTR2A—conduct disorder	0.000762	0.000769	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—HTR2A—conduct disorder	0.000762	0.000769	CbGpPWpGaD
Cinchocaine—SCN10A—brain—conduct disorder	0.000731	0.0927	CbGeAlD
Cinchocaine—SCN5A—brain—conduct disorder	0.000664	0.0842	CbGeAlD
Cinchocaine—CALM3—Immune System—EP300—conduct disorder	0.000646	0.000651	CbGpPWpGaD
Cinchocaine—CALM1—Immune System—EP300—conduct disorder	0.000625	0.00063	CbGpPWpGaD
Cinchocaine—CALM2—Immune System—EP300—conduct disorder	0.000625	0.00063	CbGpPWpGaD
Cinchocaine—CALM3—Disease—EP300—conduct disorder	0.000596	0.000601	CbGpPWpGaD
Cinchocaine—CALM1—Disease—EP300—conduct disorder	0.000577	0.000581	CbGpPWpGaD
Cinchocaine—CALM2—Disease—EP300—conduct disorder	0.000577	0.000581	CbGpPWpGaD
Cinchocaine—CALM3—brain—conduct disorder	0.000574	0.0728	CbGeAlD
Cinchocaine—CALM3—Metabolism—EP300—conduct disorder	0.000499	0.000503	CbGpPWpGaD
Cinchocaine—CALM2—Metabolism—EP300—conduct disorder	0.000483	0.000487	CbGpPWpGaD
Cinchocaine—CALM1—Metabolism—EP300—conduct disorder	0.000483	0.000487	CbGpPWpGaD
Cinchocaine—CALM2—brain—conduct disorder	0.000451	0.0572	CbGeAlD
Cinchocaine—CALM1—brain—conduct disorder	0.000449	0.0569	CbGeAlD
Cinchocaine—CALM3—Signaling Pathways—EP300—conduct disorder	0.000418	0.000421	CbGpPWpGaD
Cinchocaine—CALM1—Signaling Pathways—EP300—conduct disorder	0.000404	0.000407	CbGpPWpGaD
Cinchocaine—CALM2—Signaling Pathways—EP300—conduct disorder	0.000404	0.000407	CbGpPWpGaD
Cinchocaine—BCHE—brain—conduct disorder	0.000376	0.0477	CbGeAlD
